Potential preventability of spontaneous bacterial peritonitis

Saowanee Ngamruengphong, Kenneth Nugent, Ariwan Rakvit, Sreeram Parupudi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Antibiotic prophylaxis can reduce the incidence of the first episode and recurrent episodes of spontaneous bacterial peritonitis (SBP) in high-risk cirrhotic patients. However, recent data suggest that SBP prophylaxis may be underused. It is unclear how many cases of cirrhosis that develop SBP might actually be prevented with antibiotic prophylaxis. Aims: To determine the number of "preventable" cases of SBP and the adherence to standard guidelines for the use of antibiotic prophylaxis. Methods: A retrospective analysis of our patients diagnosed with SBP was performed. AASLD Guidelines (2004) for SBP prophylaxis include prior SBP, gastrointestinal (GI) hemorrhage, ascitic fluid (AF), protein ≤ 1 g/dl, or serum bilirubin ≥ 2.5 mg/dl. "Preventable (P) SBP" was defined as SBP occurring where prophylaxis was indicated but was not administered. "Non-preventable (NP) SBP" was defined as SBP that occurred despite proper adherence to the guidelines. "Inevitable (I) SBP" were those cases of SBP occurring in the absence of a documented indication for prophylaxis. Results: A total of 259 patients with cirrhosis underwent paracentesis; 29 had confirmed SBP. Eighteen of the 29 patients (62%) had "P-SBP", one (3%) had "NP-SBP", and ten (34%) had "I-SBP". In the P-SBP cases, the overlooked indications for prophylaxis were GI hemorrhage (n, %) (8, 44%), serum bilirubin ≥ 2.5 mg/dl (6, 33%), prior SBP (2, 11%) and AF protein ≤ 1 g/dl (2, 11%). Of the P-SBP, 78% were community-acquired; 22% were nosocomial. In-hospital mortality in the P-SBP was 16% (n = 3). Only one-third of patients who survived SBP received long-term outpatient prophylaxis after discharge. Conclusions: Many cases of SBP could be prevented by adhering to the AASLD guidelines. GI hemorrhage is the most frequently overlooked indication for SBP prophylaxis. Studies identifying the reasons for non-adherence to guidelines and developing interventions to increase utilization are warranted.

Original languageEnglish (US)
Pages (from-to)2728-2734
Number of pages7
JournalDigestive Diseases and Sciences
Volume56
Issue number9
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Peritonitis
Gastrointestinal Hemorrhage
Antibiotic Prophylaxis
Guidelines
Ascitic Fluid
Bilirubin
Fibrosis
Guideline Adherence
Paracentesis

Keywords

  • Cirrhosis
  • Prevention
  • Quality of health care
  • Spontaneous bacterial peritonitis

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Potential preventability of spontaneous bacterial peritonitis. / Ngamruengphong, Saowanee; Nugent, Kenneth; Rakvit, Ariwan; Parupudi, Sreeram.

In: Digestive Diseases and Sciences, Vol. 56, No. 9, 09.2011, p. 2728-2734.

Research output: Contribution to journalArticle

Ngamruengphong, Saowanee ; Nugent, Kenneth ; Rakvit, Ariwan ; Parupudi, Sreeram. / Potential preventability of spontaneous bacterial peritonitis. In: Digestive Diseases and Sciences. 2011 ; Vol. 56, No. 9. pp. 2728-2734.
@article{7db4687428344111b4ab1f1016070b1a,
title = "Potential preventability of spontaneous bacterial peritonitis",
abstract = "Background: Antibiotic prophylaxis can reduce the incidence of the first episode and recurrent episodes of spontaneous bacterial peritonitis (SBP) in high-risk cirrhotic patients. However, recent data suggest that SBP prophylaxis may be underused. It is unclear how many cases of cirrhosis that develop SBP might actually be prevented with antibiotic prophylaxis. Aims: To determine the number of {"}preventable{"} cases of SBP and the adherence to standard guidelines for the use of antibiotic prophylaxis. Methods: A retrospective analysis of our patients diagnosed with SBP was performed. AASLD Guidelines (2004) for SBP prophylaxis include prior SBP, gastrointestinal (GI) hemorrhage, ascitic fluid (AF), protein ≤ 1 g/dl, or serum bilirubin ≥ 2.5 mg/dl. {"}Preventable (P) SBP{"} was defined as SBP occurring where prophylaxis was indicated but was not administered. {"}Non-preventable (NP) SBP{"} was defined as SBP that occurred despite proper adherence to the guidelines. {"}Inevitable (I) SBP{"} were those cases of SBP occurring in the absence of a documented indication for prophylaxis. Results: A total of 259 patients with cirrhosis underwent paracentesis; 29 had confirmed SBP. Eighteen of the 29 patients (62{\%}) had {"}P-SBP{"}, one (3{\%}) had {"}NP-SBP{"}, and ten (34{\%}) had {"}I-SBP{"}. In the P-SBP cases, the overlooked indications for prophylaxis were GI hemorrhage (n, {\%}) (8, 44{\%}), serum bilirubin ≥ 2.5 mg/dl (6, 33{\%}), prior SBP (2, 11{\%}) and AF protein ≤ 1 g/dl (2, 11{\%}). Of the P-SBP, 78{\%} were community-acquired; 22{\%} were nosocomial. In-hospital mortality in the P-SBP was 16{\%} (n = 3). Only one-third of patients who survived SBP received long-term outpatient prophylaxis after discharge. Conclusions: Many cases of SBP could be prevented by adhering to the AASLD guidelines. GI hemorrhage is the most frequently overlooked indication for SBP prophylaxis. Studies identifying the reasons for non-adherence to guidelines and developing interventions to increase utilization are warranted.",
keywords = "Cirrhosis, Prevention, Quality of health care, Spontaneous bacterial peritonitis",
author = "Saowanee Ngamruengphong and Kenneth Nugent and Ariwan Rakvit and Sreeram Parupudi",
year = "2011",
month = "9",
doi = "10.1007/s10620-011-1647-5",
language = "English (US)",
volume = "56",
pages = "2728--2734",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Potential preventability of spontaneous bacterial peritonitis

AU - Ngamruengphong, Saowanee

AU - Nugent, Kenneth

AU - Rakvit, Ariwan

AU - Parupudi, Sreeram

PY - 2011/9

Y1 - 2011/9

N2 - Background: Antibiotic prophylaxis can reduce the incidence of the first episode and recurrent episodes of spontaneous bacterial peritonitis (SBP) in high-risk cirrhotic patients. However, recent data suggest that SBP prophylaxis may be underused. It is unclear how many cases of cirrhosis that develop SBP might actually be prevented with antibiotic prophylaxis. Aims: To determine the number of "preventable" cases of SBP and the adherence to standard guidelines for the use of antibiotic prophylaxis. Methods: A retrospective analysis of our patients diagnosed with SBP was performed. AASLD Guidelines (2004) for SBP prophylaxis include prior SBP, gastrointestinal (GI) hemorrhage, ascitic fluid (AF), protein ≤ 1 g/dl, or serum bilirubin ≥ 2.5 mg/dl. "Preventable (P) SBP" was defined as SBP occurring where prophylaxis was indicated but was not administered. "Non-preventable (NP) SBP" was defined as SBP that occurred despite proper adherence to the guidelines. "Inevitable (I) SBP" were those cases of SBP occurring in the absence of a documented indication for prophylaxis. Results: A total of 259 patients with cirrhosis underwent paracentesis; 29 had confirmed SBP. Eighteen of the 29 patients (62%) had "P-SBP", one (3%) had "NP-SBP", and ten (34%) had "I-SBP". In the P-SBP cases, the overlooked indications for prophylaxis were GI hemorrhage (n, %) (8, 44%), serum bilirubin ≥ 2.5 mg/dl (6, 33%), prior SBP (2, 11%) and AF protein ≤ 1 g/dl (2, 11%). Of the P-SBP, 78% were community-acquired; 22% were nosocomial. In-hospital mortality in the P-SBP was 16% (n = 3). Only one-third of patients who survived SBP received long-term outpatient prophylaxis after discharge. Conclusions: Many cases of SBP could be prevented by adhering to the AASLD guidelines. GI hemorrhage is the most frequently overlooked indication for SBP prophylaxis. Studies identifying the reasons for non-adherence to guidelines and developing interventions to increase utilization are warranted.

AB - Background: Antibiotic prophylaxis can reduce the incidence of the first episode and recurrent episodes of spontaneous bacterial peritonitis (SBP) in high-risk cirrhotic patients. However, recent data suggest that SBP prophylaxis may be underused. It is unclear how many cases of cirrhosis that develop SBP might actually be prevented with antibiotic prophylaxis. Aims: To determine the number of "preventable" cases of SBP and the adherence to standard guidelines for the use of antibiotic prophylaxis. Methods: A retrospective analysis of our patients diagnosed with SBP was performed. AASLD Guidelines (2004) for SBP prophylaxis include prior SBP, gastrointestinal (GI) hemorrhage, ascitic fluid (AF), protein ≤ 1 g/dl, or serum bilirubin ≥ 2.5 mg/dl. "Preventable (P) SBP" was defined as SBP occurring where prophylaxis was indicated but was not administered. "Non-preventable (NP) SBP" was defined as SBP that occurred despite proper adherence to the guidelines. "Inevitable (I) SBP" were those cases of SBP occurring in the absence of a documented indication for prophylaxis. Results: A total of 259 patients with cirrhosis underwent paracentesis; 29 had confirmed SBP. Eighteen of the 29 patients (62%) had "P-SBP", one (3%) had "NP-SBP", and ten (34%) had "I-SBP". In the P-SBP cases, the overlooked indications for prophylaxis were GI hemorrhage (n, %) (8, 44%), serum bilirubin ≥ 2.5 mg/dl (6, 33%), prior SBP (2, 11%) and AF protein ≤ 1 g/dl (2, 11%). Of the P-SBP, 78% were community-acquired; 22% were nosocomial. In-hospital mortality in the P-SBP was 16% (n = 3). Only one-third of patients who survived SBP received long-term outpatient prophylaxis after discharge. Conclusions: Many cases of SBP could be prevented by adhering to the AASLD guidelines. GI hemorrhage is the most frequently overlooked indication for SBP prophylaxis. Studies identifying the reasons for non-adherence to guidelines and developing interventions to increase utilization are warranted.

KW - Cirrhosis

KW - Prevention

KW - Quality of health care

KW - Spontaneous bacterial peritonitis

UR - http://www.scopus.com/inward/record.url?scp=80054726308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054726308&partnerID=8YFLogxK

U2 - 10.1007/s10620-011-1647-5

DO - 10.1007/s10620-011-1647-5

M3 - Article

VL - 56

SP - 2728

EP - 2734

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 9

ER -